Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
644 |
|
| Actual shortage: | 11 (2%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (85%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
81 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VARDENAFIL | 5 mg | Tablets | Resolved | 2019-01-21 | 2020-05-20 | 73041 |
| MYLAN-VARDENAFIL | 10 mg | Tablets | Resolved | 2019-01-21 | 2019-03-06 | 73044 |
| MYLAN-VARDENAFIL | 20 mg | Tablets | Resolved | 2019-01-21 | 2019-03-06 | 73047 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2021-11-23 | 206 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3346 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3360 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-02 | 2021-11-23 | 8719 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-03 | 2021-11-23 | 8764 |
| MYLAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-05 | 2017-07-17 | 9154 |
| MYLAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-05 | 2017-07-17 | 9158 |
| MYLAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-05 | 2017-07-17 | 9162 |
| MYLAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-05 | 2017-07-17 | 9165 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-08-01 | 2018-07-05 | 17818 |
| MYLAN-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-08-29 | 2017-09-30 | 20575 |
| MYLAN-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-08-29 | 2017-09-30 | 20578 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2017-06-21 | 2019-05-23 | 13528 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2017-06-21 | 2018-02-03 | 13532 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Avoided shortage | 2019-06-04 | 2019-06-18 | 85554 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2019-06-25 | 2019-07-17 | 87460 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2020-07-02 | 2020-10-01 | 119316 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-OLANZAPINE | 5MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53775 |
| MYLAN-OLANZAPINE | 7.5MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53780 |
| MYLAN-OLANZAPINE | 10MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53783 |
| MYLAN-OLANZAPINE | 15MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53790 |
| MYLAN-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94048 |
| MYLAN-SIMVASTATIN | 5MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94112 |
| MYLAN-SIMVASTATIN | 10MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94117 |
| MYLAN-SIMVASTATIN | 20MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94122 |
| MYLAN-SIMVASTATIN | 40MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94127 |
| MYLAN-SIMVASTATIN | 80MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94132 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-IPRATROPIUM SOLUTION | 0.25MG | SOLUTION | Discontinued | 2017-11-23 | 2018-07-04 | 30368 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| GEMCITABINE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6698 |
| GEMCITABINE FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6701 |
| AZITHROMYCIN FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-07-17 | 2018-02-15 | 15804 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51668 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51671 |